Company Overview of Q-Med Scandinavia, Inc.
Q-Med Scandinavia, Inc. provides products for the treatment of vesicoureteral reflux (VUR). Its products include DEFLUX, which is a gel that is used in endoscopic injections to treat VUR. The company is based in Princeton, Virginia. Q-Med Scandinavia, Inc. operates as a subsidiary of Q-Med AB. As of June 4, 2009, Q-Med Scandinavia, Inc. operates as a subsidiary of Oceana Therapeutics, Inc.
103 Carnegie Center
Princeton, NJ 08540
Key Executives for Q-Med Scandinavia, Inc.
Q-Med Scandinavia, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Q-Med Scandinavia, Inc., please visit www.deflux.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.